Digital health case studyPharmaceutical
Benchmarking Global Competitor Partnerships to Prioritise Digital Health Strategy
Client context: Leading global biopharma company
Strategic question
Where are competitors investing and partnering in Digital Health, and what should that mean for our own portfolio strategy?
Decision enabled
What the client could do next
Enabled the client to reprioritise partnership focus and evaluate high-potential ventures against a defensible comparative framework.
Approach
Powered by HealthTech Alpha, Galen Growth mapped the Digital Health partnerships of the client’s top 25 competitors across 15 countries and two therapeutic areas. We then co-developed a relevance-scoring framework using proprietary venture signals to prioritise the most decision-relevant opportunities.
Methodology
Strategic interpretation
Clarified where competitors were building capability, where strategic white space existed and which ventures merited closer evaluation against a defensible comparative framework.
